Ascelia Pharma AB (CHIX:ACES) Dividends Received


CHIX:ACES Ascelia Pharma AB CHIX:ACES
28 GF Score
Price kr3.29
! 1 Warning Sign
View Full Analysis

What is Ascelia Pharma AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:ACES
28GF Score
Ascelia Pharma AB CHIX:ACES
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascelia Pharma AB Business Description

Other Exchanges ACE:Sweden
Address Hyllie Boulevard 34, Malmo, SWE, 215 32
Ascelia Pharma AB is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. It has two drug candidates, Orviglance and Oncoral, in development. Orviglance (manganese chloride tetrahydrate) is an oral contrast agent for MR imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with impaired kidney function, and Oncoral is a novel oral irinotecan tablet in development.
28GF Score

Get the complete analysis for CHIX:ACES

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.29
Price